MedTrace Logo

Multicenter Pilot-study for the Therapy of Medulloblastoma of Adults

NCT01614132 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 33

Last updated 2020-03-31

No results posted yet for this study

Summary

The purpose of this study is to determine whether a combination of a radiochemotherapy (vincristin) and a following maintenance chemotherapy (vincristin, cisplatin and CCNU) in adult patients with medulloblastoma is tolerable.

Conditions

Interventions

DRUG

maintenance chemotherapy (vincristin, cisplatin and CCNU)

maintenance chemotherapy of maximum of 8 cycles á 42 days

RADIATION

Radiotherapy

Radiotherapy of the partial brain

Sponsors & Collaborators

  • University of Regensburg

    lead OTHER

Principal Investigators

  • Peter Hau, MD · Department of Neurology, University of Regensburg

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-01-31
Primary Completion
2018-10-31
Completion
2018-10-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01614132 on ClinicalTrials.gov